L-glutamine incorporation into tumor-cell proteins (null)

"L-glutamine incorporation into tumor-cell proteins" refers to the **metabolic pathway by which cancer cells utilize L-glutamine, an amino acid, for synthesizing cellular proteins**. This is not a single molecular entity or canonical drug target such as an enzyme, receptor, or transporter. Instead, it describes a key aspect of **tumor cell metabolism**, where L-glutamine serves both as a nitrogen donor and carbon source for biosynthetic processes essential for rapid cell proliferation[1][2][3]. In many cancers, oncogenic signaling pathways—such as those involving MYC—upregulate both **glutaminase** expression and **glutamine transporter SLC1A5**, leading to increased uptake and catabolism of glutamine[1]. The incorporated glutamine supports protein synthesis directly by providing amino groups and indirectly by fueling other biosynthetic reactions through its conversion into other amino acids like glutamate and asparagine[3]. Elevated activity of enzymes like **glutaminase** is often required for tumor growth. While several anti-cancer strategies aim at inhibiting key steps in this metabolic network—such as blocking glutaminase activity—the phrase "L-glutamine incorporation into tumor-cell proteins" does not refer to any one actionable therapeutic target but rather describes an important biological phenomenon observed in many tumors. **Consequently, there are no drugs that directly target this "incorporation" process itself, though drugs may target enzymes or transporters involved in glutamine metabolism. Similarly, there are no direct biomarkers for the process, although related enzymes such as glutaminase or glutamine synthetase may serve as biomarkers[2]. Safety concerns are not applicable to the metabolic process itself; instead, they relate to targeting associated pathways or enzymes.** Because this entry refers broadly to a metabolic function rather than a specific molecule or druggable entity, it should be flagged as incorrect if used where only discrete targets are appropriate.

Other names

Glutamine incorporation into tumor-cell proteinsTumor cell protein synthesis from glutamineGlutamine utilization in cancer cells

null (not applicable to this process itself; see description for related mechanisms)